Deep Brain Stimulation for Cerebral Palsy
Trial Summary
Do I need to stop my current medications for the trial?
The trial does not specify if you need to stop taking your current medications. However, it mentions that participants should have a history of trying oral medications without adequate relief, so it's possible you may need to continue them.
What data supports the effectiveness of the treatment Cerebellar Deep Brain Stimulation for Cerebral Palsy?
Research shows that Cerebellar Deep Brain Stimulation (DBS) can help improve movement issues in people with cerebral palsy, such as reducing muscle stiffness and involuntary movements. Studies have reported improvements in spasticity, speech, and overall functional status, with continued benefits over time.12345
Is deep brain stimulation safe for treating cerebral palsy and other conditions?
How is Cerebellar Deep Brain Stimulation different from other treatments for cerebral palsy?
Cerebellar Deep Brain Stimulation (DBS) is unique because it involves placing electrodes in the cerebellum (a part of the brain that helps control movement) to reduce symptoms like spasticity and improve motor function. Unlike medications, which can be unsatisfactory, this treatment directly targets brain areas to help manage movement disorders in cerebral palsy.12689
What is the purpose of this trial?
The purpose of this study is to test the safety of placing Deep Brain Stimulators (DBS) in a part of the brain called the cerebellum and using electrical stimulation of that part of the brain to treat movement symptoms related to cerebral palsy. Ten children and young adults with dyskinetic cerebral palsy will be implanted with a Medtronic Percept Primary Cell Neurostimulator. We will pilot videotaped automated movement recognition techniques and formal gait analysis, as well as collect and characterize each subject's physiological and neuroimaging markers that may predict hyperkinetic pathological states and their response to therapeutic DBS.
Research Team
Marta San Luciano Palenzuela
Principal Investigator
University of California, San Francisco
Eligibility Criteria
This trial is for children and young adults aged 7-25 with dyskinetic cerebral palsy (DCP), who have tried oral medications without enough relief. They should be able to attend follow-up visits, have a history of brain injury before their motor symptoms started, and not have major cerebellar abnormalities on an MRI.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Open-label Phase
Participants undergo an open label phase to titrate stimulation and determine optimal stimulation settings
Randomized Blinded Phase
Participants start three cycles of randomized, paired 8-week exposure periods, each pair including effective stimulation followed by sham stimulation, or vice versa
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Cerebellar Deep Brain Stimulation
Cerebellar Deep Brain Stimulation is already approved in United States for the following indications:
- Dyskinetic cerebral palsy
- Movement disorders in cerebral palsy
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
National Institutes of Health (NIH)
Collaborator